| ID | Name | CAS | Data |
MW (g/mol) |
| 58-231-1 |
3«alpha»,5«beta»,7«beta»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 753.40 |
| 58-254-6 |
17«alpha»-hydroxy-5«beta»-androstan-3-one (2-enol), per-TMS
|
|
2 | 434.80 |
| 58-318-5 |
(2,4-Dichlorophenoxy) acetic acid, 2(2-aminoethoxy)ethanol salt
|
|
2 | 326.17 |
| 58-419-3 |
Propionic acid,2-[(4-amino-1,3-dimethyl-1h-pyrazol-5-yl)thio]-,d-lactam
|
13568-77-9 |
2 | 197.26 |
| 58-420-1 |
Silane, [[(3«alpha»,5«beta»)-pregn-20-ene-3,17,20,21-tetrayl]tetrakis(oxy)]tetrakis[trimethyl-
|
42599-94-0 |
2 | 639.22 |
| 58-454-4 |
L-Glutamic acid, N-(tert-butyldimethylsilyl)-, bis(tert-butyldimethylsilyl) ester
|
107715-97-9 |
2 | 489.91 |
| 58-498-6 |
9H-Purine, 9-[2-deoxy-3-O-(trimethylsilyl)-«beta»-D-erythro-pentofuranosyl]-6-(trimethylsiloxy)-2-[(trimethylsilyl)amino]-, 5'-[bis(trimethylsilyl) phospate]
|
32645-71-9 |
2 | 708.13 |
| 58-559-8 |
5-«alpha»-Pregnan-3-«beta»-ol, 20-«alpha»-GlcNAc, MeTMS
|
|
2 | 812.43 |
| 58-702-8 |
5-«beta»-Pregnan-11-«beta»,20-«beta»-diol-3-one, MO-TMS
|
|
2 | 507.90 |
| 58-725-3 |
7H-pyrrolo[2,3-d]pyrimidine, 4-chloro-7-cyclopentyl-
|
212268-44-5 |
2 | 221.69 |
| 58-737-0 |
4-Oxo-2-pyridinium-3-(2,4,6-trioxo-1,3-diazacyclohexylidene-5)-1-naphthoxide
|
|
2 | 361.31 |
| 58-746-0 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3,4-dimethoxy, methylboronate
|
|
2 | 310.15 |
| 58-814-4 |
17«alpha»-hydroxy-5«beta»-androstan-3-one (3-enol), per-TMS
|
|
2 | 434.80 |
| 58-854-0 |
9-Dodecyn-1-ol, dimethyl(dimethyl(dimethyl(pyrid-3-ylmethoxy)silyloxy)silyloxy)silyl ether
|
|
2 | 495.88 |
| 58-861-2 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTMS
|
|
2 | 448.83 |
| 58-973-8 |
Anthracene, 1,2,3,4,5,6,7,8-octahydro-cis-1,2-diol, DTBS
|
|
2 | 358.59 |
| 59-013-2 |
2-methyl-2,4,4,6,6-pentaphenyl-[1,3,5,2,4,6]cyclotrisiloxane
|
|
2 | 532.82 |
| 59-260-8 |
4-Aminobenzoic acid, N,N-bis(pentafluoropropionyl)-, tert.-butyldimethylsilyl ester
|
|
2 | 543.43 |
| 59-293-2 |
3A,11B,21-Trihydroxy-5A-pregnan-20-one, MO TMS
|
|
2 | 596.08 |
| 59-308-5 |
5«beta»-Androst-1-en-3«alpha»-ol-17-one,bis-TMS
|
|
2 | 432.79 |
| 59-315-7 |
3,3-Dimethylacrylic acid, dimethyl(3,3,3-trifluoropropyl)silyl ester
|
|
2 | 254.32 |
| 59-334-6 |
Benzene-1,4-dicarboxylic acid, 2,5-dihydroxy, bis-DTBS
|
|
2 | 478.73 |
| 59-343-6 |
Galactotriose: aD-Galp(1->3)-bDGalp(1->4)-DGal, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 59-355-3 |
5«beta»-Pregnane-3«alpha»,16«alpha»,20«alpha»-triol, EO-TMS
|
|
2 | 539.03 |
| 59-437-2 |
13,14-Dihydro-15-keto-PGF2A, BO-TMS, isomer # 1
|
|
2 | 642.15 |
| 59-525-4 |
19-Nor-5,7,9(10)-cholestatrien-3.beta.-ol, TMS
|
|
2 | 440.79 |
| 59-607-3 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,17-O)-diTMSi, (20-O)-TBDMSi
|
|
2 | 595.13 |
| 59-648-8 |
4-Bis[(tert-butyldimethylsilyl)oxy]phosphoryl-N-(tert-butyldimethylsilyl)butan-1-amine
|
|
2 | 495.90 |
| 59-679-4 |
1H-pyrazolo[3,4-d]pyrimidine, 4-(methylthio)-1-beta-d-ribofuranosyl-, 2',3',5'-tribenzoate
|
106488-32-8 |
2 | 610.64 |
| 59-769-4 |
(E)-10-Dodecenoic acid, 9-hydroxy-12-oxo, methyl ester, MSTFA adduct, OH-TMS, # 2
|
|
2 | 513.74 |
| 59-845-9 |
tert-Butyl-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 687.06 |
| 59-896-3 |
5-«beta»-Pregnan-3-«alpha»-ol-11-one, MO-TMS
|
|
2 | 419.72 |
| 59-906-1 |
3,6-dideoxy-arabino-hexonic acid, 1,4-lactone, TMS
|
|
2 | 290.51 |
| 60-071-6 |
1-Propene-1,2,3-tricarboxylic acid, tris(trimethylsilyl) ester, (Z)-
|
55530-71-7 |
2 | 390.65 |
| 60-090-5 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-6.«alpha»,17«beta»-diol, bisTMIPS
|
|
2 | 557.01 |
| 60-126-5 |
3«alpha»,6«alpha»,7«alpha»,12«alpha»-Tetrahydroxy-5«beta»-cholanic acid, methyl ester, TMS
|
|
2 | 727.32 |
| 60-136-4 |
3«alpha»,7«alpha»,17«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | 697.30 |
| 60-223-7 |
Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, lactone
|
55515-29-2 |
2 | 466.86 |
| 60-286-8 |
Cyclohexanecarboxylic acid, 1-[3-(2-chloroethyl)-3-nitrosoureido]-, ethyl ester
|
13991-74-7 |
2 | 305.76 |
| 60-296-7 |
Androsta-1,4-dien-6«beta»,17«beta»-diol-3-one,tris-TMS
|
|
2 | 518.95 |
| 60-425-3 |
17-«beta»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, 17-TMS
|
|
2 | 390.67 |
| 60-437-0 |
5«alpha»-Androstane-3«beta»,6«alpha»,17«beta»-triol, TMS
|
|
2 | 525.00 |
| 60-438-9 |
Silane, [[(3.beta.)-lanosta-8,24-dien-3-yl]oxy]trimethyl-
|
|
2 | 498.91 |
| 60-487-5 |
1,2-Cyclobutane-dicarboximide, n-ethyl-4-dimethylamino-3,3-dimethyl-
|
91638-02-7 |
2 | 224.30 |
| 60-517-1 |
2,2,4,4,6,6,8,8,10,10,12,12,14-tridecamethyl-12-(2-cyanoethyl)-[1,3,5,7,9,11,13,2,4,6,8,10,12,14]cycloheptasiloxane
|
|
2 | 558.11 |
| 60-527-0 |
Formamide, n-(6-amino-3,4-dihydro-4-oxo-5-pyrimidinyl)-n-benzyl-
|
|
2 | 244.25 |
| 60-570-2 |
5«beta»-Androst-1-en-3«beta»-ol-17-one,bis-TMS
|
|
2 | 432.79 |
| 60-632-3 |
5«beta»-Cholestane-3«alpha»,7«alpha»,12«alpha»,24S,25-pentol, TMS
|
|
2 | 799.55 |
| 60-788-1 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)butoxy-
|
|
2 | 296.52 |
| 60-879-0 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«beta»-triol, tris-TMS
|
|
2 | 553.05 |
| 60-881-7 |
Ethanol, 2-[(6-amino-2-chloro-5-nitro-4-pyrimidinyl)amino]-
|
|
2 | 233.61 |
| 60-948-3 |
3A,11B,17A,21-Tetrahydroxy-5B-pregnan-20-one, MO TMS
|
|
2 | 684.26 |
| 61-019-3 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androst-1-en-3-one, 17-TMS
|
|
2 | 374.63 |
| 61-031-9 |
Silane, dimethyl(dimethyl(3,5-difluorophenoxy)silyloxy)(3,5-difluorophenoxy)-
|
|
2 | 390.48 |
| 61-088-7 |
4-O-«beta»-Galactopyranosyl-D-mannopyranose, octakis(trimethylsilyl) ether (isomer 1)
|
|
2 | 919.75 |
| 61-097-7 |
Silane, chlorodiethyl(2,6-dimethylnon-1-en-3-yn-5yloxy)-
|
|
2 | 286.92 |
| 61-365-9 |
5-«alpha»-Pregnan-3-«alpha»-ol-11-one, MO-TMS
|
|
2 | 419.72 |
| 61-378-5 |
Galactitol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-
|
18919-39-6 |
2 | 615.26 |
| 61-689-0 |
13,14-Dihydro-6,15-diketo-PGF1A, EO-TMS isomer # 3
|
|
2 | 673.16 |
| 61-720-4 |
ent-6-«alpha»,7-«alpha»,12-«beta»-Trihydroxykaurenonic acid, methyl ester, TMS
|
|
2 | 581.02 |
| 61-852-8 |
3«alpha»,16«beta»,17«alpha»-Trihydroxy-5«beta»-androstane, tris-TMS
|
|
2 | 525.00 |
| 62-093-0 |
5-tertbutyldimethylsilyloxy-6-chloro-2,3,6-trideoxy-L-threo-hexono-1,4-lactone
|
|
2 | 278.85 |
| 62-102-9 |
3,5-Dideoxy-erythro-pentonic acid, 1,4-lactone, TMS
|
|
2 | 188.30 |
| 62-166-9 |
Pyruvic acid, (4-hydroxy-6-methylpyrimidin-2-yl)hydrazone (keto form)
|
92610-88-3 |
2 | 210.19 |
| 62-182-1 |
Silane, diethyl(2,7-dimethyloct-1-en-3-yn-5-yloxy)dodecyloxy-
|
|
2 | 422.77 |
| 62-236-1 |
Oxadiazole, 1,2,4-,5-carboxamide,3-(5-nitrofuran-2-yl)-
|
|
2 | 224.13 |
| 62-439-6 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-dibutyl, 1,3-bis-(chloromethyl)
|
|
2 | 375.48 |
| 62-472-9 |
2,3,4,5-Tetrafluorobenzyl alcohol, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 305.34 |
| 62-507-0 |
2,2,4,4,6,6,8-heptamethyl-8-(2-cyanoethyl)-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 335.66 |
| 62-542-1 |
Oxymesterone (Androst-4-en-17A-methyl-4,17B-diol-3-one), TMS
|
|
2 | 534.99 |
| 62-650-1 |
Benzeneacetic acid, «alpha»,4-bis[(tert-butyldimethylsilyl)oxy]-3-methoxy-, tert-butyldimethylsilyl ester
|
|
2 | 540.97 |
| 62-766-3 |
2,4-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
2 | 496.90 |
| 62-808-6 |
5-«alpha»-Pregnan-20-«beta»-ol-3,11-dione, MO-TMS
|
|
2 | 462.74 |
| 62-824-8 |
Triazolo[4,5-d]pyrimidine, 1h-v-, 5-amino-7-ethoxy-
|
91314-05-5 |
2 | 180.17 |
| 62-872-5 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether (isomer 2)
|
|
2 | 392.67 |
| 62-908-5 |
D-Selenomethionine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
2 | 338.30 |
| 62-983-2 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, tridecyl ester
|
|
2 | 499.61 |
| 63-019-1 |
Phthalimide, n-[(2(3h)-oxo-3-phenyl-3-benzofuranyl)methyl]-
|
|
2 | 369.38 |
| 63-036-2 |
Methyl chol-4,6-dien-3-one-24-oate, oxime, TMS
|
|
2 | 471.75 |
| 63-055-1 |
4-Butyl-1-phenylpyrazolidine-3,5-diol, O,O'-bis(trimethylsilyl ether
|
|
2 | 376.64 |
| 63-083-0 |
Silanamine, N-[2-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-N,1,1,1-tetramethyl-2-[(trimethylsilyl)oxy]ethyl]-
|
56114-63-7 |
2 | 413.77 |
| 63-188-4 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTBDMSi, (17-O)-TMSi
|
|
2 | 637.21 |
| 63-231-5 |
2-Hydroxybut-2-enedioic acid, O-trimethylsilyl-, bis(trimethylsilyl) ester
|
|
2 | 348.61 |
| 63-250-4 |
5«alpha»-Androst-1-ene-3«beta»,17«alpha»-diol, per-TMS
|
|
2 | 434.80 |
| 63-252-2 |
[13C] 16«alpha», 17-H2-16, 17-(OH)2-GA4 methyl ester TMS ether
|
|
2 | 596.98 |
| 63-377-4 |
5-«beta»-Pregnan-3-«beta»,20-«beta»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 63-419-7 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-(3-chloropropyl)
|
|
2 | 356.27 |
| 63-455-7 |
[1,2,5] Thiadiazolo[3,4-d]pyrimidine-5,7-bis (2-hydroxyethylamino)-
|
|
2 | 256.29 |
| 63-474-6 |
Hexahydro-3,3,5-trimethyl-2-p-tolyl-1,4,2-diazaphosphorine-2-oxide
|
|
2 | 252.30 |
| 63-487-2 |
4-P-tolylsulfonylhydrazo-6-methyl-1,3,3a,7-tetrazaindene
|
109445-77-4 |
2 | 318.35 |
| 63-514-1 |
O,O'-Bis(tert-butyldimethylsilyl) ,2-trimethylsilylamino-9-(2-hydroxyethoxymethyl)-purin-6-ol ether
|
|
2 | 441.75 |
| 63-541-1 |
13,14-Dihydro-6,15-diketo-PGF1A, EO-TMS, isomer # 1
|
|
2 | 673.17 |
| 63-542-0 |
17«beta»-Hydroxy-4-estren-3-one-methyloxime, trimethylsilyl deriv.
|
124460-92-0 |
2 | 375.62 |
| 63-555-6 |
Imidazolidine-4-thione, 2,2,5,5-tetramethyl-1-nitroso-
|
152450-70-9 |
2 | 187.26 |
| 63-659-1 |
17-«alpha»-Hydroxy-17-«beta»-methyl-5-«beta»-androst-1-en-3-one, per-TMS
|
|
2 | 446.81 |
| 63-858-0 |
Silane, diphenylheptyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 489.44 |
| 63-883-2 |
5-«alpha»-Pregnan-3-«beta»,20-«beta»-diol-11-one, MO-TMS
|
|
2 | 507.90 |
| 63-923-7 |
1,1,3,3-Tetramethyl-1,3-bis([5-methyl-2-(1-methylethenyl)hex-4-en-1-yl]oxy)disiloxane
|
|
2 | 438.79 |
| 63-949-9 |
(20S)-5«alpha»-cholestan-3«beta»,20,25-triol, DMESI
|
|
2 | 679.29 |
| 63-966-0 |
4,6-Bis([tert-butyl(dimethyl)silyl]oxy)pteridin-2-amine
|
|
2 | 407.66 |
|
« Previous Results
Next Results »
|